Monograph Development: Why and When to Participate

This article explores another proactive advocacy approach that a bio/pharmaceutical company may take through participation in the development of new and revised monographs in the various pharmacopoeias.

Related Content:

Pharmacopoeial Compliance Series

Pharmacopoeia Compliance: A Practical Guide

Monograph Development: How to Participate; How to Harmonize

A Case Study in Pharmacopoeia Compliance: Excipients and Raw Materials